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Abstract: Optical imaging is emerging as a non-invasive and non-ionizing 
method for breast cancer diagnosis. A hand-held optical imager has been 
developed with coregistration facilities towards flexible imaging of different 
tissue volumes and curvatures in near real-time. Herein, fluorescence-
enhanced optical imaging experiments are performed to demonstrate deeper 
target detection under perfect and imperfect (100:1) uptake conditions in 
(liquid) tissue phantoms and in vitro. Upon summation of multiple scans 
(fluorescence intensity images), fluorescent targets are detected at greater 
depths than from single scan alone. 
©2010 Optical Society of America 
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Systems; (110.0113) Imaging through turbid media; (110.3080) Infrared imaging; (110.6955) 
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1. Introduction 
Optical imaging is a growing area of research, with efforts to translate the technology to the 
clinic and aid in early-stage breast cancer detection, diagnosis, and/or prognosis of the 
disease. Optical imaging systems are developed by various research groups with differences in 
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their imaging technique (continuous-wave, frequency-domain, or time-domain), and source-
detector configuration (single or multiple sources/detectors that are either for point/area 
imaging). While most of these systems are bulky and yet capable of three-dimensional (3D) 
tomographic imaging of large tissue volumes, there are a whole class of hand-held optical 
imaging systems that are portable and capable of two-dimensional (2D) spectroscopic imaging 
[1–6]. 
In the past five years, our Optical Imaging Laboratory has been focused in developing a 
hand-held (portable) optical imaging system that is capable of 3D tomographic imaging 
beyond the 2D spectroscopic imaging capabilities (available to date) [7]. The recently 
developed hand-held optical imager is unique in its following features: (i) a probe head to 
image a large surface area simultaneously; (ii) a simultaneous illumination and detection 
geometry that enhances the overall imaging time; (iii) a flexible probe head to contour to any 
tissue curvature and volume; and (iv) a novel coregistration approach to acquire the positional 
information using a motion tracker (towards 3D tomography studies). The feasibility of 2D 
target detection(s) and 3D tomographic analysis using this hand-held optical imager has been 
demonstrated from tissue phantom and in-vitro fluorescence imaging studies [7–9]. During 
these studies, a single scan in the region of interest was acquired to detect and recover the 
embedded target(s) tomographically (using manually coregistered optical images). However, 
it was observed that as the target depth was increased and/or its volume decreased, the target 
was not detectable from 2D images, nor was it recovered from 3D tomography studies. An 
alternate imaging approach of using multiple-scans from various locations of the tissue 
surface was developed (using automatically coregistered optical images) and its feasibility to 
detect deeper targets was assessed [10]. 
In the current work, the recently developed multi-scan imaging approach is extensively 
assessed to determine the target detection limits of our hand-held optical imager. Studies were 
performed using the liquid tissue phantoms in order to determine the extent of improvement 
upon the previous studies using single-scan. Studies were also extended to in vitro tissue 
models in order to assess the performance of the device in a non-uniform (or heterogeneous) 
scattering background, in order to better mimic human tissue. 
2. Materials and methods 
2.1 Instrumentation 
The instrumentation for the hand-held optical imaging system as shown in Fig. 1 is composed 
of a laser diode source (785 nm, 530 mW) and intensified charge-coupled device (ICCD) 
detector (−24 V DC detector power), which are connected to the probe face via optical fibers. 
The 4 x 9 cm2 hand-held probe head contains 6 illumination points (shown as large red dots in 
Fig. 1) and 165 detection points (spaced 0.5 cm apart) which illuminate and collect the signal 
simultaneously for rapid data acquisition. A collimator-diffuser package splits the NIR light 
from the laser diode into 6 simultaneous sources. The laser output from each of these 6 
sources at the probe end onto the tissue geometry is only 2 mW or less at each illumination 
point (due to >90% intensity losses from the collimator-diffuser package). The imaging 
system is capable of operating in both the continuous wave (CW) and frequency domain 
mode. The CW mode is used here as a fast measurement technique (near real-time) to enable 
collection of multiple scans without greatly increasing the imaging time. During imaging 
studies, the integration time of the ICCD camera is kept constant (0.2 sec) and only the gain 
settings at the intensifier end is varied. Further details of the instrumentation have been 
described elsewhere [7]. 
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 Fig. 1. Instrumentation for the hand-held probe based optical imaging system. 
2.2 Coregistered imaging process 
Image coregistration onto the 3D tissue geometry being scanned is necessary in order to 
perform 3D tomography studies. This is because the location of the image must be known 
with respect to the geometry of the phantom (or tissue) being imaged. Coregistered imaging 
involves tracking the position and orientation of the probe in real time and combining the 
positional information with the optical measurements to accurately position the image on the 
discretized phantom or tissue geometry. This is carried out as a three-step process (illustrated 
in Fig. 2) using MATLAB/LabVIEW software developed in house [10]. An acoustic tracker is 
implemented on the probe head to enable real-time tracking of the 3D position and orientation 
of the probe (in six degrees of freedom) with respect to the phantom surface (Step #1). The 
positional information is used to accurately position the 2D image of fluorescence intensity at 
the corresponding location on the discretized phantom geometry. The positional information 
is fused with the optical measurement data collected from the hand-held device (Step #2) to 
generate a 3D coregistered image of the phantom with the fluorescence intensity (or any other 
optical measurement) data at the probe’s location (Step #3). The entire coregistration process 
is automated such that it takes ~35 seconds to acquire a single coregistered image or scan (i.e. 
carry out all the 3 steps described above). The actual time to acquire an optical image at a 
single location of the probe is ~1 sec (i.e. 0.2 sec detector integration time × 5 repetitions for 
each CW image), and the remaining time (~34 sec) is towards the coregistration process. The 
coregistration process is repeated at each probe location, during a multi-scan imaging 
technique (i.e. optical images are acquired from multiple locations of the probe on the tissue 
surface). 
2.3 Validation of coregistered imaging in phantoms 
In order to quantitatively determine the accuracy of the tracked location in comparison to the 
true location of the probe on a cubical tissue phantom, the probe was placed at five different 
positions of known [x,y,z] coordinates and the tracking position was recorded (5 repetitions at 
each location). The average and standard deviation of the tracked location, and its total 
distance-off from the true location at each position number were measured. The average total 
distance off is ~0.19 cm. For these measurements, the probe was held in place with a lab jack 
and the error in measurements is primarily due to error in the tracking system and possibly 
some movement of the phantom during positioning of the probe. Currently work is carried out 
to improve the accuracy of the tracking system. 
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 Fig. 2. Three-step coregistered imaging process. In Step #1, the source and detector locations 
are tracked in real-time with respect to the phantom. In Step #2, a raw image (of optical 
measurement) is collected and used to generate a 2D surface contour plot of the corresponding 
(here fluorescence intensity) data. In Step #3, the positional information is used to accurately 
coregister the image to the probe’s location on the discretized phantom mesh. 
2.4 Experimental studies 
Experimental studies were performed initially using the simple case of the uniform liquid 
tissue phantom and were then extended to more realistic in vitro models. Phantom 
experiments were performed using tissue phantoms (as in the previous studies [7,8]) 
composed of 1% Liposyn (800 mL) in a 10 × 10 × 10 cm3 acrylic cube. Acrylic sphere targets 
of sizes 0.23 - 0.45 cm3 filled with 1 µM indocyanine green (ICG) were placed at different 
depths (2.5-4.0 cm) from the imaging surface to represent a tumor. Experiments were 
performed increasing the depth by 0.5 cm until the target was no longer detected. The 
experimental set-up is shown in Fig. 3. The probe was placed in full contact with the phantom 
surface and multiple scans (2D coregistered images) were collected using the method 
described in section 2.5 below. 
 
Fig. 3. Experimental set-up for phantom studies. (A) A spherical target filled with 1 µM 
indocyanine green is enclosed within the cubical phantom to represent a tumor. (B) The 
phantom is composed of a 1% Liposyn solution to mimic the optical properties of human breast 
tissue. 
To represent the heterogeneous nature of human tissue, studies were also performed in 
vitro using minced chicken breast (480 mL) combined with 1% Liposyn (260 mL) in a 10 × 
10 × 10 cm3 acrylic cube in order to introduce a background of non-uniform scattering. The 
0.45 cm3 fluorescent target was placed at different depths between 2.0 and 4.0 cm, until the 
target was no longer detected. The experiments were performed for the perfect uptake case 
with tumor-to-background ratio (T:B) of 1:0 and imperfect uptake case with T:B of ~100:1. 
Table 1 summarizes the different experimental studies performed in which a target was 
detected. For each image collected, a subtraction-based post-processing technique was used to 
eliminate excitation light leakage [7]. 
2.5 Multiple-scan technique 
The multiple scan technique involves collecting a series of scans at different probe positions 
and coregistering each image to its appropriate location. A scan is defined as a 2D surface 
contour plot of fluorescence intensity data collected from a CW image (mean of 5 repeated 
#129379 - $15.00 USD Received 1 Jun 2010; revised 10 Jul 2010; accepted 12 Jul 2010; published 15 Jul 2010
(C) 2010 OSA 2 August 2010 / Vol. 1,  No. 1 / BIOMEDICAL OPTICS EXPRESS  129
images at the same location) using the ICCD based detection system. Each image is 
immediately coregistered to the discretized phantom mesh. By scanning at multiple locations, 
the weak fluorescence signal from the target (that appears at the same location on the tissue 
geometry during each scan) can possibly dominate the strong excitation light leakage (that 
tends to appear at different locations on the tissue geometry during each scan). 
Table 1. Summary of experimental studies in which a target was detected in tissue 
phantoms and in vitro. The cases where the deepest target was detected for phantom or in 
vitro, and perfect or imperfect uptake are highlighted in red. 
Experimental 
Case 
Experiment # Target Volume 
(cm3) 
Target Depth 
(cm) 
T:B 
Tissue 
Phantom 
1 0.45 3.0 1:0 
2 0.45 3.5 1:0 
3 0.23 2.5 1:0 
4 0.23 3.0 1:0 
5 0.23 3.5 1:0 
6 0.45 2.5 100:1 
7 0.45 3.0 100:1 
8 0.23 2.0 100:1 
9 0.23 2.5 100:1 
10 0.23 3.0 100:1 
In Vitro 11 0.45 2.5 1:0 
12 0.45 3.0 1:0 
13 0.45 3.5 1:0 
14 0.45 2.0 100:1 
15 0.45 2.5 100:1 
 
Different combinations of image positions were used to determine the optimal multi-scan 
method. Initially 4-5 scans were collected moving the probe 0.5 cm in the vertical direction 
between each scan. For the same experimental case, 9 scans were collected moving the probe 
in 0.25 cm increments in the vertical direction. Additionally, repeated scans were collected at 
each probe location. It was determined that collecting 2-3 repeated scans (i.e. 2-3 × 5 repeated 
images or 10-15 repeated images) at each probe location for 4-5 positions 0.5 cm apart 
resulted in better target detectability with fewer artifacts than collecting single scans (i.e. 1 × 5 
repeated images) at each probe location for 9 positions 0.25 cm apart. This can possibly be 
attributed to two reasons: (i) the inaccuracy (from instability) of the positional tracking system 
(described in section 2.3) has greater impact at smaller positional increments (e.g. 0.25 cm), 
leading to increased artifacts; and (ii) the variability in the instrument’s response is minimized 
by increasing the number of repeated scans (or images) at the same location. The number of 
repeated scans (or images) can be increased for the case where the probe location 0.25 cm 
apart. However, this further increases the overall imaging time and hence was not attempted. 
In the future, for an in vivo case, multiple images can be collected and summed from arbitrary 
probe positions and the number of scans can be optimized to minimize the overall imaging 
time and number of artifacts. The position will be known since the image is immediately 
coregistered at its location. 
3. Results 
Figure 4 shows four single images (2D contour plots of fluorescence intensity) for 
experimental case # 12 where a 0.45 cm3 fluorescent target was placed 3.0 cm deep in vitro 
under perfect uptake condition (T:B = 1:0). Multiple scans were collected as described in 
section 2.5. In each image, the true target location is indicated by a black open circle. The 
images show that the target is not detected in a single scan, and only random distributions of 
artifacts (high intensity signals that appear in the image which do not originate from the 
target) are visible. Upon summation of eight scans, the fluorescent signal is detected at the 
target location (Fig. 5). This can be attributed to the random distribution of artifacts that 
appear in different locations for each single scan, while the signal from the target remains in 
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the same location relative to its coregistered position on the phantom. Upon summation of the 
coregistered images, the random signals from the artifacts tend to diminish compared to the 
consistent signal from the target, which tends to intensify. 
Figure 6 shows the result for summated multi-scan images for experimental cases 5, 10, 
13, and 15 (highlighted in Table 1). Case 5 represents a 0.23 cm3 target placed 3.5 cm deep in 
the tissue phantom under perfect uptake conditions (T:B = 1:0). The target was detected close 
to the true location and no artifacts were present. Case 10 represents a 0.23 cm3 target placed 
3.0 cm deep in the tissue phantom under imperfect uptake condition (T:B = 100:1). The target 
was detected at the true location with some diffused signal around it. Case 13 represents a 
0.45 cm3 target placed 3.5 cm deep in-vitro under perfect uptake conditions (T:B = 1:0). The 
target was detected at the true location with artifacts also visible far from the target location. 
These artifacts can be attributable to the heterogeneous nature of the in vitro phantom.  
 
Fig. 4. Coregistered images from single scans (2D contour plots of fluorescence intensity data) 
at four probe positions for experimental case #12 (a 0.45 cm3 fluorescent target placed 3.0 cm 
deep, x-dimension in-vitro phantom under T:B = 1:0). In each image, the white dotted line 
represents the probe position with respect to the phantom and the black open circle represents 
the true target location. 
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 Fig. 5. Summated image of multiple scans shown in Fig. 4 (experimental case #12). The 
summed image represents summation of 8 single scans, where 2 scans were collected at each of 
the 4 probe positions shown in Fig. 4. The black open circle represents the true target location. 
 
Fig. 6. Summed images of multiple coregistered scans from the four best experimental cases 
listed in Table 1. The black open circle indicates the true target location for each case. 
Case 15 represents a 0.45 cm3 target placed 2.5 cm deep in-vitro under imperfect uptake 
conditions (T:B = 100:1). The target was detected close to the true location along with 
minimal artifacts around it. 
The initial experiments designed to detect deeper targets consisted of performing a single 
scan at 4-5 positions moving the probe 0.5 cm in the vertical (z) direction. For deeper targets 
(>3.0 cm), heterogeneous (in vitro) phantoms, and/or imperfect uptake cases, the target was 
not detected upon summation of four or five scans. However, it was observed that when 
multiple repeated scans were collected at the same location for each probe position, the targets 
were detectable. In other words, increasing the number of repeated scans is as important as 
increasing the number of scan locations towards deep target detection under heterogeneous 
and/or imperfect uptake conditions. 
The results presented here demonstrate that deeper and smaller targets can be detected 
using the multiple-scan approach than using a single-scan alone. The impact of these results 
extend beyond target detection in 2D in that the information can be used as a priori 
information to aid 3D reconstruction using a single frequency-domain image (or scan) 
towards deeper target recovery (future work). 
4. Discussion 
The prime hypothesis for the current study is that a single scan (of a large area, 4 x 9 cm2) can 
fail in detecting deeper targets during a near real-time optical imaging study. Upon scanning 
at multiple locations on the surface of a tissue geometry, the possibility to detect deeper 
targets and differentiating them from artifacts tends to improve upon summing all these 
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multiple scans. The detection limits of our hand-held optical imager, the first of its kind that 
can scan large areas in near real-time, has been 2.5 cm for a 0.45 cm3 target under T:B = 1:0 
from the past studies [8] involving a single scan from the region of interest on the tissue 
geometry. In the current study, it was clearly observed that upon summation of the intensity 
signals from multiple scans of the tissue surface, targets of smaller volume and as deep as 3.5 
cm were detectable. However, artifacts start appearing when the target depth is increased, the 
target volume is decreased, and or heterogeneity of the background increased. The reasons for 
these artifacts are two-fold: (i) The uneven source strength distribution of the 6 simultaneous 
sources affects the ability to detect the target depending on the proximity of the target to the 
stronger sources. As multiple scans are collected the strong source may move away from the 
target resulting in a more diffused signal which produces a greater number of artifacts upon 
subtraction of the background. (ii) The positional information of the hand-held probe is not 
accurately coregistered due to the instability of the motion tracking device, which can lead to 
misalignment of the target signal in the multiple images. As a result, some signals which 
originated from the target can be mistaken as artifacts due to their improper location in the 
image. Currently, work is carried out to homogenize the source strength distribution by 
altering the instrumentation set-up at the source end, and also developing alternate motion 
tracking approaches that are stable and more accurate in comparison to the current device. 
Researchers in the past have demonstrated detection of targets as deep as 5 cm using their 
hand-held optical devices [6]. However, the detection was typically a point location that was 
spectroscopically obtained from the tissue surface. In addition, the specificity of getting a 
negative result (not detecting any target) in the absence of the target (i.e. in the surrounding 
tissues) is not described. In other words, unlike the current hand-held optical imager that can 
produce 2D images over large areas in near real-time, the other hand-held imagers have a 
limited imaging area (mostly point-based imaging) and typically produce only spectroscopic 
measurements from a few sources/detectors. 
The advantage of the current hand-held imager’s optical data is that it can be applied 
towards 3D tomography studies, since the positional location of the optical data with respect 
to the 3D tissue geometry is coregistered during imaging studies. Hence, the implementation 
of the multi-scan imaging approach and using the summated images towards immediate 2D 
deep target detection and future 3D tomographic analysis is feasible. Although the present 
study is focused on fluorescence-enhanced optical imaging, the multi-scan summation and 
imaging approach is applicable for absorption-based diffuse optical imaging studies as well. 
In the area of fluorescence tomographic imaging, Sevick’s research group was one of the 
first groups to demonstrate 3D fluorescence optical tomography in clinically relevant sized 
tissue phantoms, using large bulky optical imaging instrumentation [11]. Fluorescent targets 
of 1 cm3 volume were recovered at depth up to 2.8 cm under perfect uptake conditions. The 
first in vivo 3D fluorescence optical tomography of breast cancer in human subjects was 
demonstrated by Corlu et. al. where tumors were recovered in vivo up to 2.0 cm deep in 
human breast tissue [12]. From our past 3D tomography studies using the hand-held imager 
on large tissue phantoms, 0.45 cm3 targets as deep as 2.5 cm were recovered in uniform tissue 
phantoms under perfect uptake conditions [8]. 
In a recent in vivo study using a simulated fluorescent target, a single scan using our hand-
held optical imager was able to detect a 0.23 cm3 target ~2.5 cm deep in human breast tissue 
[9]. These past studies demonstrate the potential that upon using multiple scans and applying 
the summation approach, deeper and smaller targets can become detectable from the tissue 
surface. In addition, these summated images can also assist in tomographically recovering 
deeper targets beyond what is demonstrated to date in the area of fluorescence optical 
tomography. However, the developed hand-held optical imager is limited to reflectance based 
imaging, which tends to limit the recovery of the true target’s depth during 3D tomography. 
Currently, research is carried out to develop alternate imaging approaches using the hand-held 
device such that trans-illumination measurements can also be acquired in an attempt to 
improve the target depth recovery (during 3D tomography). 
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5. Conclusion 
A hand-held optical imager has been developed with unique features of flexibility to contour 
to different tissue curvatures, ability to rapidly image a large area, and coregistration 
capabilities to enable 3D tomography. Herein we have demonstrated improved detection 
limits via application of a multiple-scan technique. The multi-scan imaging approach is 
facilitated by the use of fast 2D coregistered imaging in CW mode. Previous results using 
single-scan imaging showed that the greatest target depth detected was 2.5 cm and 1.5 cm for 
a 0.45 cm3 target in a (liquid) tissue phantom under perfect and imperfect uptake conditions, 
respectively. By using the multi-scan technique, this depth was improved to 3.5 cm for a 
smaller target (0.23 cm3) under the T:B = 1:0 condition. Under imperfect uptake conditions 
(T:B = 100:1), the detectable target depth was increased from 1.5 cm to 3.0 cm. Since these 
results were promising, studies were extended to in vitro models, which better represent the 
non-uniformity of human tissue. From these in-vitro studies the target was detected at depths 
of 3.5 cm and 2.5 cm for perfect (1:0) and imperfect uptake (100:1) cases, respectively. These 
studies demonstrate that summation of multiple coregistered images can be used towards 
deeper target detection than is capable from single scans alone. In a clinical setting, this 
technique can be used to acquire multiple images quickly in order to detect the presence of a 
tumor, determine its 2D location within the tissue, and also perform 3D tomography studies 
(as a follow-up). Thus, the hand-held optical imager has potential for fast 2D imaging and 3D 
tomography in the clinical setting for breast cancer diagnosis. 
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